NCT04206657

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 42 (actual)
• Sponsor: Kyowa Kirin Co., Ltd. · Industry
• Sex: All
• Age: 20 Years – 39 Years
• Healthy volunteers: Accepted

Summary

The primary objective is to evaluate the pharmacokinetic profile of KHK7580 in Chinese healthy adult volunteers. The secondary objective is to evaluate its safety and pharmacodynamics.

Conditions

• Healthy Volunteer

Interventions

Type	Name	Description
DRUG	1mg KHK7580	Single oral dose administration of 1mg KHK7580
DRUG	3mg KHK7580	Single oral dose administration of 3mg KHK7580
DRUG	6mg KHK7580	Single oral dose administration of 6mg KHK7580
DRUG	12mg KHK7580	Single oral dose administration of 12mg KHK7580
DRUG	6mg KHK7580 for 8days	multiple oral dose administration of 6mg KHK7580 for 8days

Timeline

• Start date: 2019-12-20
• Primary completion: 2021-06-17
• Completion: 2021-06-17
• First posted: 2019-12-20
• Last updated: 2021-09-08

Locations

1 site across 1 country: China